silicosis; lung; pulmonary fibrosis SILICOSIS IS A MAJOR OCCUPATIONAL lung disease caused by the inhalation of crystalline silica [silicon dioxide (SiO 2 )], a cytotoxic and fibrogenic mineral dust (3, 46) . The specific mechanisms by which silicosis develops are not well understood. However, the interaction between crystalline silica and the alveolar macrophage (AM) is generally considered to be an early and critical step that initiates a cascade of events resulting in histopathological evidence of injury and fibrosis (1, 6, 10, 27) . In a recent in vivo study (52) examining the response of AMs and interstitial macrophages to the airway delivery of silica, AMs were by far the predominant type of macrophage engulfing silica particles. Although AMs attempt to protect the lung by ingesting the silica particulates from the alveolar spaces, silica continues to cause injury and promote release of toxic radicals, inflammatory mediators, and chemotaxins that contribute to the pathogenesis of disease (10, 17) .
Silica, primarily ␣-quartz, is cytotoxic to AMs in vitro (9, 22, 33, 39, 47) . Direct toxicity to cells such as AMs is one proposed mechanism by which silica is thought to initiate an inflammatory response in silicosis (10) . The mechanism by which silica exerts its toxic effect on AMs is unclear, although recent studies (5, 11, 14, 20, 24, 38, 42, 43) indicated that cellular injury may be mediated in part by oxygen-and/or nitrogen-derived free radicals.
Evidence from both animal models (4, 21, 40, 41) and humans (9) suggests that silica exposure results in acute cellular injury in vivo (4, 9, 21, 40, 41) . However, silica-induced injury in vivo appears to be markedly diminished compared with injury in vitro (7, 12, 18) . The reason for this relative protection from silicainduced injury in vivo is unknown. It is well recognized that after acute silica exposure, an excessive amount of surfactant accumulates in the lungs (8, 19, 23, 25) . Similarly, there is a marked elevation in surfactant apoprotein (SP) A, SP-B, and SP-D (13, 29, 31, 36, 45) . Previous studies have shown that surfactant phospholipids diminish silica-mediated cytotoxicity in vitro (2, 22, 39, 47) and in vivo (2) . However, the possible role of SPs in this initial silica-AM interaction is unstudied.
SP-A is the major protein component of alveolar surfactant. It is a C-type lectin possessing a carbohydrate recognition domain and is structurally homologous to C1q (26) . SP-A has been shown to specifically attach to AMs (32, 37) , and there is substantial evidence to indicate that SP-A plays an important role in host defense, especially in the response of AMs to microorganisms (28, 44, 51) . Recently, a study (35) indicated that SP-A as well as SP-D is upregulated during acute inflammation in the lung, suggesting that SPs may act as acute-phase reactants similar to mannose binding protein in the serum.
In this study, in vitro cytotoxicity of silica to rat AMs was quantified with a 51 Cr release cytotoxity assay (34) . Silica-mediated toxicity to AMs was dependent on the duration of incubation and the concentration and size of the silica. SP-A reduced the direct cytotoxic effect of silica on AMs, and this protective effect was reversed by the addition of D-mannose, a sugar that has high affinity for the carbohydrate recognition domain, and by anti-SP-A polyclonal antibody. These data support the hypothesis that the elevation in SP-A after acute exposure to silica may represent an appropriate host response that occurs in vivo to limit the injurious effect of silica on specific lung cells.
METHODS
Isolation and culture of AMs. Pathogen-free female SpragueDawley rats (Harlan Sprague Dawley, Indianapolis, IN) were housed in open cages and killed with an intraperitoneal injection of Beuthanasia-D solution (Schering-Plough Animal Health, Kenilworth, NJ). The trachea was cannulated after a midline neck incision was made, and the lungs were lavaged six to seven times with 8-to 10-ml aliquots of Hanks' balanced salt solution without Ca 2ϩ or Mg 2ϩ (GIBCO BRL, Life Technologies, Grand Island, NY) plus 0.6 mM EDTA, 100 U/ml of penicillin, and 100 µg/ml of streptomycin. Approximately 50 ml of fluid were obtained from each rat. Lavage fluid was centrifuged (1,200 g for 5 min), and the supernatant was discarded. To preferentially remove any red blood cells, the cells were suspended in lysing solution containing 0.01 M KHCO 3 and 0.15 M NH 4 Cl and repelleted. The cells were resuspended in 0.9% NaCl, and cell number was determined with hemocytometer counts. A cell differential was performed by examination of cytopreparation smears (Cytospin II, Shandon Southern Instruments, Sewickley, PA) that demonstrated that Ͼ95% of the cells were AMs. AMs were suspended in Dulbecco's modified Eagle's medium (DMEM; BioWhittaker Bioproducts, Walkersville, MD) supplemented with glutamine (0.6 mg/ml), penicillin (100 U/ml), streptomycin (100 µg/ml), gentamicin (4 µg/ml), amphotericin B (0.5 µg/ml), and 20 mM HEPES (pH 7.4). The AMs were then plated on 96-well tissue culture plates (Becton Dickinson, Lincoln Park, NJ) at a density of 2.5 ϫ 10 5 cells/well in 0.2 ml of DMEM. The cells were allowed to adhere for a minimum of 4 h at 37°C in a 5% CO 2 atmosphere. Before use, monolayer AMs were gently washed with DMEM to remove any nonadherent cells.
Silica. Crystalline silica was obtained from US Silica (Berkeley Springs, WV). The purity and ␣-quartz structure of the crystals were confirmed by X-ray powder diffraction (Scintag XDS-2000 powder diffractometer, Scintag, Cupertino, CA). Silica was fractionated by size with repetitive centrifugation in distilled water at graded speeds. Silica crystal diameter was determined by averaging the length of the long and short axes as previously described (49). Averages were determined from 100 crystal measurements/fraction. Size fractions were confirmed by fluorescence-activated cellsorting analysis (FACStar Plus flow cytometer and FACScan analyzer, Becton Dickinson, Mountain View, CA). Crystal sizes were 18 Ϯ 6 µm for fraction 1, 8 Ϯ 3 µm for fraction 2, 4 Ϯ 1.5 µm for fraction 3, and Ͻ2 µm for fraction 4. Each fraction was air-dried and then heated to 250°C for 2 h to destroy endotoxin. The crystals were suspended in Hanks' balanced salt solution or DMEM for all experiments. Aluminum oxide (Al 2 O 3 ) in the form of corundum (Aldrich, Milwaukee, WI) was used as a nontoxic inorganic crystal control with a mean crystal size of 2.4 µm (48) .
SP-A and anti-SP-A antibody preparation.
Rat SP-A and anti-SP-A polyclonal antibody production (rabbit anti-rat) were prepared as previously described (50, 51) . Levels of endotoxin in SP-A preparations were determined by quantitative chromogenic Limulus amebocyte assay (BioWhittaker). The sensitivity of the assay is Ͻ1 ng endotoxin/ml.
Cytotoxicity assay. Cultured AMs in 96-multiwell tissue culture dishes were labeled with 51 Cr as previously described (34) . Briefly, isolated AMs were incubated for at least 4 h with 51 Cr (NEN, Boston, MA) in DMEM containing 5% NuSerum (Becton Dickinson, Bedford, MA). After incubation, the medium was removed, and the cells were washed three times with fresh DMEM to remove unincorporated 51 Cr just before each assay was initiated.
AMs were incubated in supplemented DMEM at 37°C as indicated above but in the absence of NuSerum. The effect of time and concentration on incubation was determined by exposing silica at varying concentrations (0-250 µg/ml, size 3-6 µm ) to cultured 51 Cr-labeled AMs for 2, 4, 6, 8, 10, or 12 h. AMs were also incubated with different particle sizes (Ͻ2, 3-6, 5-11, and 12-24 µm) for 4 h. Surface area of the fractionated silica particles was determined by the Janus green dye assay according to Daniel et al. (15) . These data were used to calculate the mass of the various silica fractions that would result in the same surface area. The masses at a surface area of 1.6 cm 2 for each fraction were 37.2 µg (12-24 µm) for fraction 1, 30.1 µg (5-11 µm) for fraction 2, 25 µg (3-6 µm) for fraction 3, and 10.5 µg (Ͻ2 µm) for fraction 4. To characterize silica-induced cytotoxicity to cultured rat AMs, the following conditions were selected for all subsequent experiments involving the effect of SP-A antibody (5 µg/ml): 4-h incubation with Ͻ2-µm silica at a concentration of 250 µg silica/ml. These studies were repeated in the presence and absence of SP-A (5 µg/ml) or SP-A with and without anti-SP-A (2.5 µg/ml) or D-mannose (50 mM). SP-A or NuSerum (5 µg protein/ml, a synthetic serum product used as a protein control, was added to the silica immediately before addition to the AMs so that the AMs would be exposed simultaneously to the protein and the silica.
After each incubation, the microwell plate containing the monolayer AMs was centrifuged in microplate carriers at 800 g for 5 min. To determine the amount of 51 Cr released into the medium, one-half of the supernatant was removed from each well and transferred to a labeled 12 ϫ 75-mm tube. Triton X-100 (100 µl of a 10% stock solution; Sigma, St. Louis, MO) was added to the remaining half of the medium to disrupt the AM cell layer. The disrupted cell suspension was transferred to a labeled 12 ϫ 75-mm tube. The counts per minute in the supernatant and the corresponding cell fractions were determined in a gamma counter (Gamma 5500, Beckman Instruments, Fullerton, CA). The percent of 51 Cr release (%R) was calculated as %R ϭ [2A/(A ϩ B)] ϫ 100, where A is 50% of 51 Cr free in the medium and B is A plus 51 Cr remaining incorporated in AMs. The cytotoxic index (CI) was determined with a control AM monolayer as CI ϭ [(%R experimental Ϫ %R control )/ (100 Ϫ %R control )] ϫ 100, where %R experimental is the %R in the treated cells and %R control is the %R in the control cells. A CI of 0 reflects that no release above that resulting from the ''spontaneous release'' from control cells occurred, whereas a CI of 100 indicates that all the ''releasable'' 51 Cr was released from the cells.
Statistical analysis. All results are expressed as means Ϯ SE of at least three separate experiments performed in triplicate. Data were compared with Student's t-test or oneway ANOVA. Multiple comparison analysis was performed with Dunnett's test (16) . http://ajplung.physiology.org/ induced cytotoxicity to cultured AMs in a concentration-and time-dependent manner (Fig. 1) . Silica at concentrations of 16, 31, 62, 125, and 250 µg/ml was incubated with 51 Cr-labeled AMs for 2, 4, 6, 8, 10, and 12 h. The results show that each concentration of silica plateaus between 4 and 6 h and that the CI is directly proportional to the concentration of the silica.
RESULTS

Silica toxicity to
When the silica crystals were sorted by size (Ͻ2, 3-6, 5-11, and 12-24 µm), smaller crystals were more toxic to AMs than larger crystals with quantities of equivalent mass. For example, 12-to 24-µm silica crystals resulted in a CI of Ϫ0.103 Ϯ 0.803, whereas those Ͻ 2 µm resulted in a CI of 61.3 Ϯ 1.853 (P Ͻ 0.05; Fig. 2A ). As expected, each progressively smaller size fraction of silica was associated with a greater surface area (Fig.  2B) . These results were used to determine the relationship between surface area and CI (Fig. 2C) . We next determined the influence of particle size with an equivalent surface area for each fraction on AM cytotoxicity (1.6 cm 2 ). For the smaller silica particles (3-6 and Ͻ2 µm), the CIs were 20.8 Ϯ 0.9 and 32.7 Ϯ 0.5, respectively (P Ͻ 0.05; Fig. 3 ). For the larger particle sizes of 5-11 and 12-24 µm, there was no significant cytotoxicity, with CIs of 1.9 Ϯ 4.0 and 1.8 Ϯ 2.5, respectively (P Ͼ 0.05). Thus silica toxicity to AMs was concentration and time dependent. Furthermore, silica toxicity was dependent on crystal size even when the surface area was held constant, with smaller silica crystals being more toxic than larger ones. Although silica induced cytotoxicity to cultured rat AMs, Al 2 O 3 , a nonfibrogenic inorganic dust, did not.
Effect of SP-A on silica-mediated injury to AMs. SP-A significantly diminished 51 Cr release from silicaexposed AMs from 32.9 Ϯ 2.5 to 16.6 Ϯ 1.2% (P Ͻ 0.001; Fig. 4) . A protein control also slightly decreased injury from 32.9 Ϯ 2.5 to 26.5 Ϯ 1.7% (P Ͻ 0.05), but SP-A was much more effective than the protein control in reducing 51 Cr release (P Ͻ 0.001). SP-A added to AMs in the absence of silica had no effect on baseline 51 Cr release by control AM monolayers (data not shown). When D-mannose (50 mM) was preincubated with SP-A for 20 min before the addition of silica and AMs, the protective effect of SP-A (CI of 16.6 Ϯ 1.2) was lost, with a return in the CI to 27.9 Ϯ 2.6 (P Ͻ 0.01; Fig. 4 ). Preincubation of SP-A with polyclonal anti-SP-A antibody (2.5 µg/ml) had an effect similar to D-mannose in reversing the Fig. 1 . Effect of concentration and time on silica-induced cytotoxicity to alveolar macrophages (AMs). 51 Cr-labeled AMs were exposed to indicated concentrations of silica at indicated times at 37°C. Results are means Ϯ SE from 3 experiments performed in triplicate. 51 Cr release as a marker of cell injury increased in a concentrationdependent and time-dependent manner in silica-exposed AM cultures (P Ͻ 0.05 by ANOVA). Fig. 2 . Effect of silica crystal size and surface area on silica-induced cytotoxicity to AMs. 51 Cr-labeled AMs were exposed to indicated sizes of silica crystals at a concentration of 250 µg silica/ml for 4 h at 37°C. A: silica crystal 51 Cr release as a marker of cell injury (as determined by cytotoxic index) increased in a size-dependent manner in silicaexposed AM cultures, with smaller crystalline particles (i.e., Ͻ2 µm) being the most toxic (P Ͻ 0.05 by ANOVA with repeated measures with Dunnett's method). B: surface area of size-fractionated silica was determined by Janus green assay (15) . C: surface area compared with cytotoxic index. Results are means Ϯ SE from 3 experiments performed in triplicate.
protective effect of SP-A on silica-mediated cytotoxicity. Anti-SP-A antibody reversed the SP-A inhibitory effect, from a CI of 16.6 Ϯ 1.2 to 29.9 Ϯ 3.0 (P Ͻ 0.01), a value essentially equivalent to that of AMs incubated with silica alone (32.9 Ϯ 1.5; P ϭ 0.339). Anti-SP-A antibody, nonspecific IgG antibody, and D-mannose alone showed no significant effect on 51 Cr release by AMs (data not shown).
Confirmation of these findings was provided by morphological assessment of the cultured AMs in the presence and absence of silica with and without SP-A. With phase microscopy, silica particles were easily visible (Fig. 5) . AMs in the presence of silica revealed fewer cells to be present compared with those without silica, and the AMs demonstrated typical findings of cell injury with rounding and increased light refraction, suggesting imminent lifting of the cells from the plate. SP-A significantly reduced the injurious effects of silica, with an increased number of adherent cells remaining and with less evidence of cells lifting from the plate. However, AMs in the presence of both silica and SP-A clearly demonstrated an abnormal appearance compared with normal control AMs, suggesting that silica-mediated injury was reduced but not eliminated. Fig. 3 . Effect of silica crystal size with equivalent surface area for size fractions on silica-induced cytotoxicity to AMs. With a surface area of 1.6 cm 2 for each fraction, the following amounts of silica were incubated with 51 Cr-labeled AMs for 4 h: 37.2 µg (12-24 µm) for fraction 1, 30.1 µg (5-11 µm) for fraction 2, 25 µg (3-6 µm) for fraction 3, and 10.5 µg (Ͻ2 µm) for fraction 4. Results are means Ϯ SE from 3 experiments performed in triplicate. Fig. 4 . Reversal to effect of surfactant apoprotein A (SP-A) on silica-induced cytotoxicity to AMs. 51 Cr-labeled AMs were exposed to silica crystals (Ͻ2 µm) at a concentration of 250 µg silica/ml for 4 h at 37°C in absence and presence of SP-A (5 µg/ml) alone and with anti-SP-A antibody (2.5 µg/ml) or D-mannose (50 mM). Results are means Ϯ SE from 3 experiments performed in triplicate. SP-A significantly reduced 51 Cr release from silica-exposed AMs (P Ͻ 0.05 by Student's t-test); however, in presence of anti-SP-A antibody or D-mannose, effect of SP-A was reversed (P Ͻ 0.05 for both). 
DISCUSSION
The effect of crystalline silica on AMs has been extensively studied (1, 5, 6, 10, 14, 17, 20, 22, 24, 27, 33, 38, 42, 43, 47) . Our study indicates that silica toxicity to AMs can be quantified by use of a 51 Cr assay and that the injury to AMs is dependent on the concentration and size of silica particles as well as on the time of incubation. SP-A significantly reduced the injury to AMs by silica. Interestingly, the data suggest that the carbohydrate recognition domain of SP-A is responsible for this protection. Taken as a whole, the elevation in SP-A in response to acute silica exposure may represent an appropriate host response to mitigate the injurious effects of harmful silica particles that reach the alveolar spaces.
Crystal size has been implicated as an important factor in the biological effect of silica. However, the relationship of crystal size to silica-mediated injury to AMs is unclear. Silica crystals that are 1 µm in diameter have been shown to have the greatest membranolytic effect on red blood cells (49) . Conversely, crystals Ն 5 µm in diameter have been shown to be the most fibrogenic (49) . In our study, crystals Յ 6 µm were found to have the greatest ability to injure cultured AMs. This is in agreement with a previous study by Allison et al. (1) that indicated that silica crystals of respirable size (0.5-5 µm) are highly toxic to cultured peritoneal macrophages. Smaller crystal size fractions (Ͻ2 and 3-6 µm) were more cytotoxic to AMs even when an equivalent surface area was used (Fig. 3) . This occurred even though the mass of the silica particles was less in the smaller size fractions.
Several investigators have suggested that surfactant phospholipids can diminish the cytotoxicity of ␣-quartz to AMs in vitro (22, 39, 47) and in vivo (2) . This has been proposed as one mechanism by which direct AM injury by silica in vivo can be attenuated (18) . A recent study (30) has indicated that Survanta, a mixture of both bovine phospholipids and SPs, delivered intratracheally provides in vivo protection to the lung from silica-induced release of inflammatory mediators. It is unclear, however, to what extent SPs may play a role in diminishing the cytotoxic effects of silica.
It is well known that acute silica exposure in animals greatly increases SP-A levels because airway delivery of silica is the standard method used for the isolation and purification of SP-A from animals (13, 29, 31, 36, 45) . However, the direct effect of SP-A, the major protein component of surfactant, on silica-mediated injury to AMs has not been previously studied. In our study, SP-A clearly protected AMs from the injurious effects of silica as evidenced by a standard cytotoxicity marker and phase microscopy. The protection was not complete, however, suggesting that other factors such as the presence of phospholipids, as discussed above, or perhaps other protein components such as SP-D are also important in providing protection in vivo. The ability of an SP-A antibody to reverse this protection provides evidence that a specific site on the SP-A molecule may be responsible for this protective effect. D-Mannose is a sugar that exhibits high affinity for the carbohydrate recognition domain of SP-A (26) . The finding that D-mannose reverses the effect of SP-A on silica-mediated AM injury suggests that the carbohydrate recognition domain of SP-A may play a role in this protective effect from silica.
Although our study suggests that SP-A can be protective in acute silica exposure in vitro, it is less clear whether protection of AMs in vivo will necessarily be in the best interest of the host. SP-A might serve to prolong the viability of AMs activated by silica, thereby increasing the number of AMs actively releasing the proinflammatory mediators and chemotoxins that are thought to be important in the pathogenesis of disease (17) . If true, SP-A might promote the disease process even as it affords some protection to the AMs. On the other hand, SP-A may be protective to cells other than simply to AMs. Such cells could include alveolar epithelial cells; in this case, a protective role for SP-A might help maintain the integrity of the alveolar-capillary barrier during acute exposure. Further study examining manipulation of SP-A levels in vivo is needed to determine whether this elevated SP-A response ultimately favors recovery or facilitates inflammation/ injury to the lungs of the host animal.
In summary, this study demonstrated that silica crystals are directly cytotoxic to rat AMs and that the degree of cytotoxicity is dependent on the size and concentration of crystalline silica as well as on the duration of exposure. This study indicated that SP-A reduced silica-mediated AM injury in vitro and that this effect likely involves the carbohydrate recognition domain of the SP-A molecule. These data are consistent with the hypothesis that elevated SP-A levels may serve as an appropriate host response to prevent further cell injury after acute exposure to silica. Whether SP-A elevation in vivo in response to acute silica exposure is actually beneficial to the host animal is unknown and requires further study.
